Top

Published in:

Open Access 01-06-2015 | Review Article

Combined PET/MR: The Real Work Has Just Started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17–21, 2014, Tübingen, Germany

Authors: D. L. Bailey, G. Antoch, P. Bartenstein, H. Barthel, A. J. Beer, S. Bisdas, D. A. Bluemke, R. Boellaard, C. D. Claussen, C. Franzius, M. Hacker, H. Hricak, C. la Fougère, B. Gückel, S. G. Nekolla, B. J. Pichler, S. Purz, H. H. Quick, O. Sabri, B. Sattler, J. Schäfer, H. Schmidt, J. van den Hoff, S. Voss, W. Weber, H. F. Wehrl, T. Beyer

Published in: Molecular Imaging and Biology | Issue 3/2015

Abstract

This paper summarises the proceedings and discussions at the third annual workshop held in Tübingen, Germany, dedicated to the advancement of the technical, scientific and clinical applications of combined PET/MRI systems in humans. Two days of basic scientific and technical instructions with “hands-on” tutorials were followed by 3 days of invited presentations from active researchers in this and associated fields augmented by round-table discussions and dialogue boards with specific themes. These included the use of PET/MRI in paediatric oncology and in adult neurology, oncology and cardiology, the development of multi-parametric analyses, and efforts to standardise PET/MRI examinations to allow pooling of data for evaluating the technology. A poll taken on the final day demonstrated that over 50 % of those present felt that while PET/MRI technology underwent an inevitable slump after its much-anticipated initial launch, it was now entering a period of slow, progressive development, with new key applications emerging. In particular, researchers are focusing on exploiting the complementary nature of the physiological (PET) and biochemical (MRI/MRS) data within the morphological framework (MRI) that these devices can provide. Much of the discussion was summed up on the final day when one speaker commented on the state of PET/MRI: “the real work has just started”.

Bailey DL, Barthel H, Beyer T et al (2013) Summary report of the first international workshop on PET/MR imaging, march 19-23, 2012, Tubingen, Germany. Mol Imaging Biol MIB Off Publ Acad Mol Imaging 15:361–371CrossRef

Bailey DL, Barthel H, Beuthin-Baumann B et al (2014) Combined PET/MR: where are we now? Summary report of the second international workshop on PET/MR imaging april 8–12, 2013, Tubingen, Germany. Mol Imaging Biol MIB Off Publ Acad Mol Imaging 16:295–310

Kubiessa K, Purz S, Gawlitza M et al (2014) Initial clinical results of simultaneous ¹⁸F-FDG PET/MRI in comparison to ¹⁸F-FDG PET/CT in patients with head and neck cancer. Eur J Nucl Med Mol Imaging 41:639–648CrossRefPubMed

Lee G, Kim IH, Kim SJ et al (2014) Clinical implication of PET/MR imaging in preoperative esophageal cancer staging: comparison with PET/CT, endoscopic ultrasonography, and CT. J Nucl Med Off Publ Soc Nucl Med 55:1242–1247

Beiderwellen KJ, Poeppel TD, Hartung-Knemeyer V et al (2013) Simultaneous ⁶⁸Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results. Invest Radiol 48:273–279CrossRefPubMed

Hillner BE, Liu D, Coleman RE et al (2007) The national oncologic PET registry (NOPR): design and analysis plan. J Nucl Med Off Publ Soc Nucl Med 48:1901–1908

Hillner BE, Siegel BA, Hanna L et al (2012) Impact of ¹⁸F-FDG PET used after initial treatment of cancer: comparison of the National Oncologic PET Registry 2006 and 2009 cohorts. J Nucl Med Off Publ Soc Nucl Med 53:831–837

Hillner BE, Siegel BA, Liu D et al (2008) Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the national oncologic PET registry. J Clin Oncol Off J Am Soc Clin Oncol 26:2155–2161CrossRef

Hillner BE, Siegel BA, Shields AF et al (2009) The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the national oncologic PET registry. Cancer 115:410–418CrossRefPubMed

10.

Aznar MC, Sersar R, Saabye J et al (2014) Whole-body PET/MRI: the effect of bone attenuation during MR-based attenuation correction in oncology imaging. Eur J Radiol 83:1177–1183CrossRefPubMed

11.

Bezrukov I, Schmidt H, Mantlik F et al (2013) MR-based attenuation correction methods for improved PET quantification in lesions within bone and susceptibility artifact regions. J Nucl Med Off Publ Soc Nucl Med 54:1768–1774

12.

Kuhn FP, Hullner M, Mader CE et al (2014) Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed? J Nucl Med Off Publ Soc Nucl Med 55:551–558

13.

Pace L, Nicolai E, Luongo A et al (2014) Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of ¹⁸F-deoxyglucose uptake in lesions and in normal organ tissues. Eur J Radiol 83:289–296CrossRefPubMed

14.

Preuss M, Werner P, Barthel H et al (2014) Integrated PET/MRI for planning navigated biopsies in pediatric brain tumors. Child’s Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg 30:1399–1403CrossRef

15.

Purz S, Sabri O, Viehweger A et al (2014) Potential pediatric applications of PET/MR. J Nucl Med Off Publ Soc Nucl Med 55:32S–39S

16.

Schwenzer NF, Schmidt H, Gatidis S, et al. (2013) Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with ¹⁸F-FDG-PET. JMRI-J Magn Reson Im

17.

Bisdas S, Ritz R, Bender B et al (2013) Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes. Invest Radiol 48:295–301CrossRefPubMed

18.

Wetter A (2014) Molecular research in urology 2014: update on PET/MR imaging of the prostate. Int J Mol Sci 15:13401–13405CrossRefPubMedCentralPubMed

19.

Wetter A, Lipponer C, Nensa F et al (2014) Evaluation of the PET component of simultaneous [(18) F] choline PET/MRI in prostate cancer: comparison with [(18) F] choline PET/CT. Eur J Nucl Med Mol Imaging 41:79–88CrossRefPubMed

20.

Wetter A, Lipponer C, Nensa F et al (2014) Quantitative evaluation of bone metastases from prostate cancer with simultaneous [¹⁸F] choline PET/MRI: combined SUV and ADC analysis. Ann Nucl Med 28:405–410CrossRefPubMed

21.

Wetter A, Nensa F, Schenck M et al (2014) Combined PET imaging and diffusion-weighted imaging of intermediate and high-risk primary prostate carcinomas with simultaneous [¹⁸F] choline PET/MRI. PLoS One 9:e101571CrossRefPubMedCentralPubMed

22.

Afshar-Oromieh A, Haberkorn U, Schlemmer HP et al (2014) Comparison of PET/CT and PET/MRI hybrid systems using a ⁶⁸Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience. Eur J Nucl Med Mol Imaging 41:887–897CrossRefPubMed

23.

Huellner MW, Appenzeller P, Kuhn FP, et al (2014) Whole-body nonenhanced PET/MR versus PET/CT in the staging and restaging of cancers: preliminary observations. Radiology:140090

24.

Martinez-Moller A, Souvatzoglou M, Delso G et al (2009) Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data. J Nucl Med Off Publ Soc Nucl Med 50:520–526

25.

Schramm G, Langner J, Hofheinz F et al (2013) Quantitative accuracy of attenuation correction in the Philips ingenuity TF whole-body PET/MR system: a direct comparison with transmission-based attenuation correction. MAGMA 26:115–126CrossRefPubMedCentralPubMed

26.

Prieto E, Dominguez-Prado I, Garcia-Velloso MJ et al (2013) Impact of time-of-flight and point-spread-function in SUV quantification for oncological PET. Clin Nucl Med 38:103–109CrossRefPubMed

27.

Nuyts J, Bal G, Kehren F et al (2013) Completion of a truncated attenuation image from the attenuated PET emission data. IEEE Trans Med Imaging 32:237–246CrossRefPubMed

28.

Nuyts J, Dupont P, Stroobants S et al (1999) Simultaneous maximum a posteriori reconstruction of attenuation and activity distributions from emission sinograms. IEEE Trans Med Imaging 18:393–403CrossRefPubMed

29.

Rezaei A, Defrise M, Bal G et al (2012) Simultaneous reconstruction of activity and attenuation in time-of-flight PET. IEEE Trans Med Imaging 31:2224–2233CrossRefPubMed

30.

Rezaei A, Defrise M, Nuyts J (2014) ML-reconstruction for TOF-PET with simultaneous estimation of the attenuation factors. IEEE Trans Med Imaging 33:1563–1572CrossRefPubMed

31.

Blumhagen JO, Braun H, Ladebeck R et al (2014) Field of view extension and truncation correction for MR-based human attenuation correction in simultaneous MR/PET imaging. Med Phys 41:022303CrossRefPubMed

32.

Kartmann R, Paulus DH, Braun H et al (2013) Integrated PET/MR imaging: automatic attenuation correction of flexible RF coils. Med Phys 40:082301CrossRefPubMed

33.

Defrise M, Rezaei A, Nuyts J (2012) Time-of-flight PET data determine the attenuation sinogram up to a constant. Phys Med Biol 57:885–899CrossRefPubMed

34.

Defrise M, Rezaei A, Nuyts J (2014) Transmission-less attenuation correction in time-of-flight PET: analysis of a discrete iterative algorithm. Phys Med Biol 59:1073–1095CrossRefPubMed

35.

Wurslin C, Schmidt H, Martirosian P et al (2013) Respiratory motion correction in oncologic PET using T1-weighted MR imaging on a simultaneous whole-body PET/MR system. J Nucl Med Off Publ Soc Nucl Med 54:464–471

36.

Lougovski A, Hofheinz F, Maus J et al (2014) A volume of intersection approach for on-the-fly system matrix calculation in 3D PET image reconstruction. Phys Med Biol 59:561–577CrossRefPubMed

37.

Weber WA, Ziegler SI, Thodtmann R et al (1999) Reproducibility of metabolic measurements in malignant tumors using FDG PET. J Nucl Med Off Publ Soc Nucl Med 40:1771–1777

38.

Ziegler S, Braun H, Ritt P et al (2013) Systematic evaluation of phantom fluids for simultaneous PET/MR hybrid imaging. J Nucl Med Off Publ Soc Nucl Med 54:1464–1471

39.

Oehmigen M, Ziegler S, Jakoby BW et al (2014) Radiotracer dose reduction in integrated PET/MR: implications from National Electrical Manufacturers Association phantom studies. J Nucl Med Off Publ Soc Nucl Med 55:1361–1367

40.

van den Hoff J, Oehme L, Schramm G et al (2013) The PET-derived tumor-to-blood standard uptake ratio (SUR) is superior to tumor SUV as a surrogate parameter of the metabolic rate of FDG. EJNMMI Res 3:77CrossRefPubMedCentralPubMed

41.

van den Hoff J, Lougovski A, Schramm G et al (2014) Correction of scan time dependence of standard uptake values in oncological PET. EJNMMI Res 4:18CrossRefPubMedCentralPubMed

42.

Heiss WD (2009) The potential of PET/MR for brain imaging. Eur J Nucl Med Mol Imaging 36(Suppl 1):S105–S112CrossRefPubMed

43.

Catana C, Drzezga A, Heiss WD, Rosen BR (2012) PET/MRI for neurologic applications. J Nucl Med Off Publ Soc Nucl Med 53:1916–1925

44.

Drzezga A, Barthel H, Minoshima S, Sabri O (2014) Potential clinical applications of PET/MR imaging in neurodegenerative diseases. J Nucl Med Off Publ Soc Nucl Med 55:47S–55S

45.

Garibotto V, Heinzer S, Vulliemoz S et al (2013) Clinical applications of hybrid PET/MRI in neuroimaging. Clin Nucl Med 38:13–18CrossRef

46.

Riedl V, Bienkowska K, Strobel C et al (2014) Local activity determines functional connectivity in the resting human brain: a simultaneous FDG-PET/fMRI study. J Neurosci Off J Soc Neurosci 34:6260–6266CrossRef

47.

Hitz S, Habekost C, Fürst S et al (2014) Systematic comparison of the performance of integrated whole-body PET/MR imaging to conventional PET/CT for ¹⁸F-FDG brain imaging in patients examined for suspected dementia. J Nucl Med Off Publ Soc Nucl Med 55:923–931

48.

Andersen FL, Ladefoged CN, Beyer T et al (2014) Combined PET/MR imaging in neurology: MR-based attenuation correction implies a strong spatial bias when ignoring bone. Neuroimage 84:206–216CrossRefPubMed

49.

Poynton CB, Chen KT, Chonde DB et al (2014) Probabilistic atlas-based segmentation of combined T1-weighted and DUTE MRI for calculation of head attenuation maps in integrated PET/MRI scanners. Am J Nucl Med Mol Imaging 4:160–171PubMedCentralPubMed

50.

Stegger L, Martirosian P, Schwenzer N et al (2012) Simultaneous PET/MR imaging of the brain: feasibility of cerebral blood flow measurements with FAIR-TrueFISP arterial spin labeling MRI. Acta Radiol 53:1066–1072CrossRefPubMed

51.

Werner P, Fritzsch D, Holland H et al (2014) Definition of primary and secondary glioblastoma–letter. Clin Cancer Res An Off J Am Assoc Cancer Res 20:2011–2012CrossRef

52.

Panagiotidis E, Shankar A, Afaq A, Bomanji J (2014) Assessing therapy response of secreting pineal germ cell tumor on simultaneous ¹⁸F-choline PET/MRI. Clin Nucl Med 39:e387–e388CrossRefPubMed

53.

Sander CY, Hooker JM, Catana C et al (2013) Neurovascular coupling to D2/D3 dopamine receptor occupancy using simultaneous PET/functional MRI. Proc Natl Acad Sci U S A 110:11169–11174CrossRefPubMedCentralPubMed

54.

Kendziorra K, Wolf H, Meyer PM et al (2011) Decreased cerebral alpha4beta2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer’s disease assessed with positron emission tomography. Eur J Nucl Med Mol Imaging 38:515–525CrossRefPubMed

55.

Deutschlander A, Stephan T, Riedel E et al (2008) Nicotine-induced nystagmus correlates with midpontine activation. Neuroimage 41:479–482CrossRefPubMed

56.

Mitsias PD, Ewing JR, Lu M et al (2004) Multiparametric iterative self-organizing MR imaging data analysis technique for assessment of tissue viability in acute cerebral ischemia. AJNR Am J Neuroradiol 25:1499–1508PubMed

57.

Langer DL, van der Kwast TH, Evans AJ et al (2009) Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI. J Magn Reson Imaging 30:327–334CrossRefPubMed

58.

Liu X, Langer DL, Haider MA et al (2009) Prostate cancer segmentation with simultaneous estimation of Markov random field parameters and class. IEEE Trans Med Imaging 28:906–915CrossRefPubMed

59.

Wehrl HF, Schwab J, Hasenbach K et al (2013) Multimodal elucidation of choline metabolism in a murine glioma model using magnetic resonance spectroscopy and ¹¹C-choline positron emission tomography. Cancer Res 73:1470–1480CrossRefPubMed

60.

Wehrl HF, Hossain M, Lankes K et al (2013) Simultaneous PET-MRI reveals brain function in activated and resting state on metabolic, hemodynamic and multiple temporal scales. Nat Med 19:1184–1189CrossRefPubMed

61.

Schmidt H, Brendle C, Schraml C et al (2013) Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[¹⁸F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system. Invest Radiol 48:247–255CrossRefPubMed

62.

Dukart J, Mueller K, Horstmann A et al (2011) Combined evaluation of FDG-PET and MRI improves detection and differentiation of dementia. PLoS One 6:e18111CrossRefPubMedCentralPubMed

63.

Hirsch FW, Sattler B, Sorge I et al (2013) PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner. Pediatr Radiol 43:860–875CrossRefPubMedCentralPubMed

64.

Punwani S, Cheung KK, Skipper N et al (2013) Dynamic contrast-enhanced MRI improves accuracy for detecting focal splenic involvement in children and adolescents with Hodgkin disease. Pediatr Radiol 43:941–949CrossRefPubMed

65.

Punwani S, Taylor SA, Saad ZZ et al (2013) Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI? Eur J Nucl Med Mol Imaging 40:373–385CrossRefPubMed

66.

Inaoka T, Takahashi K, Mineta M et al (2007) Thymic hyperplasia and thymus gland tumors: differentiation with chemical shift MR imaging. Radiology 243:869–876CrossRefPubMed

67.

Chawla SC, Federman N, Zhang D et al (2010) Estimated cumulative radiation dose from PET/CT in children with malignancies: a 5-year retrospective review. Pediatr Radiol 40:681–686CrossRefPubMedCentralPubMed

68.

Rauscher I, Eiber M, Furst S et al (2014) PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT. J Nucl Med Off Publ Soc Nucl Med 55:724–729

69.

Stauss J, Franzius C, Pfluger T et al (2008) Guidelines for ¹⁸F-FDG PET and PET-CT imaging in paediatric oncology. Eur J Nucl Med Mol Imaging 35:1581–1588CrossRefPubMed

70.

Schafer JF, Gatidis S, Schmidt H et al (2014) Simultaneous whole-body PET/MR imaging in comparison to PET/CT in pediatric oncology: initial results. Radiology 273:220–231CrossRefPubMed

71.

Lassmann M, Biassoni L, Monsieurs M et al (2008) The new EANM paediatric dosage card: additional notes with respect to F-18. Eur J Nucl Med Mol Imaging 35:1666–1668CrossRefPubMed

72.

Lassmann M, Treves ST (2014) Pediatric Radiopharmaceutical Administration: harmonization of the 2007 EANM Paediatric Dosage Card (Version 1.5.2008) and the (2010) North american consensus guideline. Eur J Nucl Med Mol Imaging 41:1636

73.

Dweck MR, Chow MW, Joshi NV et al (2012) Coronary arterial ¹⁸F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol 59:1539–1548CrossRefPubMed

74.

Joshi NV, Vesey AT, Williams MC et al (2014) ¹⁸F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet 383:705–713CrossRefPubMed

75.

Mewton N, Liu CY, Croisille P et al (2011) Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 57:891–903CrossRefPubMed

76.

Muzard J, Sarda-Mantel L, Loyau S et al (2009) Non-invasive molecular imaging of fibrosis using a collagen-targeted peptidomimetic of the platelet collagen receptor glycoprotein VI. PLoS One 4:e5585CrossRefPubMedCentralPubMed

77.

Schlemmer HP, Pichler BJ, Schmand M et al (2008) Simultaneous MR/PET imaging of the human brain: feasibility study. Radiology 248:1028–1035CrossRefPubMed

78.

Schmand M, Burbar Z, Corbeil JL et al (2007) BrainPET: first human tomograph for simultaneous (functional) PET and MR Imaging. J Nucl Med Off Publ Soc Nucl Med 48:45P

Title: Combined PET/MR: The Real Work Has Just Started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17–21, 2014, Tübingen, Germany
Authors: D. L. Bailey
G. Antoch
P. Bartenstein
H. Barthel
A. J. Beer
S. Bisdas
D. A. Bluemke
R. Boellaard
C. D. Claussen
C. Franzius
M. Hacker
H. Hricak
C. la Fougère
B. Gückel
S. G. Nekolla
B. J. Pichler
S. Purz
H. H. Quick
O. Sabri
B. Sattler
J. Schäfer
H. Schmidt
J. van den Hoff
S. Voss
W. Weber
H. F. Wehrl
T. Beyer
Publication date: 01-06-2015
Publisher: Springer US
Published in: Molecular Imaging and Biology / Issue 3/2015
Print ISSN: 1536-1632
Electronic ISSN: 1860-2002
DOI: https://doi.org/10.1007/s11307-014-0818-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Combined PET/MR: The Real Work Has Just Started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17–21, 2014, Tübingen, Germany

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2015

[99mTc]cFLFLF for Early Diagnosis and Therapeutic Evaluation in a Rat Model of Acute Osteomyelitis

BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [18F] Fluorocholine PET-CT (Phase I Study)

Imaging Caspase-3 Activation as a Marker of Apoptosis-Targeted Treatment Response in Cancer

SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors

Quantitative Multi-modal Brain Autoradiography of Glutamatergic, Dopaminergic, Cannabinoid, and Nicotinic Receptors in Mutant Disrupted-In-Schizophrenia-1 (DISC1) Mice

[18F]Fluoromethylcholine as a Chemotherapy Response Read-Out in Prostate Cancer Cells